Open Access Journal of Clinical Trials

Scope & Guideline

Connecting Global Minds in Clinical Trials.

Introduction

Welcome to the Open Access Journal of Clinical Trials information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Open Access Journal of Clinical Trials, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1179-1519
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2009 to 2024
AbbreviationOPEN ACCESS J CLIN T / Open Access J. Clin. Trials
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The Open Access Journal of Clinical Trials focuses on disseminating innovative clinical research findings, methodologies, and best practices across various health disciplines. Its core areas emphasize the importance of rigorous trial designs, participant engagement, and the evaluation of health interventions.
  1. Clinical Trial Methodologies:
    The journal emphasizes the development and evaluation of various clinical trial designs, including randomized controlled trials, pilot studies, and pragmatic trials, ensuring robust methodological standards.
  2. Patient-Centric Research:
    Research focused on participant compliance, satisfaction, and engagement in clinical trials highlights the importance of patient perspectives in the design and implementation of health interventions.
  3. Interventions for Vulnerable Populations:
    A consistent focus on clinical trials targeting specific age groups or vulnerable populations, such as older adults, individuals with chronic conditions, and patients with mental health issues, showcases the journal's commitment to addressing health disparities.
  4. Translational Research:
    The journal publishes findings that bridge the gap between laboratory research and clinical practice, promoting the application of scientific discoveries in real-world settings.
  5. Holistic and Multidomain Interventions:
    Research on multifaceted interventions, particularly for chronic conditions and mental health, emphasizes the complexity of health challenges and the need for comprehensive treatment approaches.
Recent publications reflect an evolving focus within the journal, highlighting emerging themes that resonate with contemporary health challenges and research priorities.
  1. COVID-19 Related Research:
    The journal has seen a significant increase in studies related to COVID-19, including vaccine efficacy and treatment protocols, reflecting the ongoing global health crisis and the need for timely research.
  2. Mental Health Interventions:
    There is a growing emphasis on mental health, particularly interventions designed for specific populations, such as older adults with HIV, indicating a recognition of the increasing importance of mental well-being in overall health outcomes.
  3. Home-Based Healthcare Interventions:
    Research focused on home-based interventions, such as home blood pressure monitoring, is trending, showcasing a shift towards patient-centered care that empowers individuals to manage their health in familiar settings.
  4. Social Support Mechanisms:
    Emerging themes around social support interventions for chronic disease management, like diabetes, highlight the importance of community and social networks in improving health outcomes.

Declining or Waning

While the journal continues to evolve, certain themes have shown a decrease in prominence in recent publications. These waning scopes suggest shifting priorities within the clinical trial research landscape.
  1. Traditional Medicine Trials:
    Although the journal has recently published work on traditional Chinese medicine, the broader focus on alternative and complementary therapies appears to be declining, possibly due to a growing emphasis on evidence-based practices.
  2. Single-Dose Trials:
    The publication of single-dose trials has become less frequent, indicating a possible shift towards more comprehensive intervention studies that assess longer-term effects and multi-dose strategies.
  3. Niche Pharmaceutical Interventions:
    Research on specific pharmaceutical alternatives, such as the Gabapentinoid for cocaine consumption problems, has decreased, suggesting a trend towards broader health interventions rather than niche pharmaceutical solutions.

Similar Journals

Istanbul Medical Journal

Advancing medical knowledge for a healthier tomorrow.
Publisher: GALENOS PUBL HOUSEISSN: 2619-9793Frequency: 4 issues/year

Istanbul Medical Journal is a prominent open-access journal published by GALENOS PUBL HOUSE, dedicated to disseminating high-quality research in the field of medicine since its inception in 1994. The journal, identifiable by its ISSN 2619-9793 and E-ISSN 2148-094X, serves as a critical platform for healthcare professionals, researchers, and students who aim to share innovative studies and advancements within diverse medical domains. Its commitment to open access ensures that crucial findings and discussions are readily available to a global audience, fostering collaboration and knowledge exchange among the scientific community. Located in Istanbul, Türkiye, the journal not only contributes to the medical literature landscape but also emphasizes the importance of accessibility in research, aligning with current academic trends that prioritize the transmission of knowledge across barriers. As a resource for those involved in healthcare and medical research, the Istanbul Medical Journal plays a vital role in shaping future developments in medicine.

Journal of the Chinese Medical Association

Exploring Innovations in Chinese Medicine
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1726-4901Frequency: 12 issues/year

Journal of the Chinese Medical Association, published by LIPPINCOTT WILLIAMS & WILKINS, is a prominent peer-reviewed journal in the field of general medicine, specifically focused on advancements and research within the Chinese medical community. Established in 2003 and with a scope that spans diverse medical disciplines, this journal has positioned itself as a key resource for medical professionals, researchers, and academics interested in both clinical practices and health policy in Taiwan and the broader context of Asian medicine. With an impressive Scopus ranking of 69 out of 636 in the general medicine category and a notable percentile rank of 89th, the journal is recognized for its contributions to medical science. Although it does not currently provide open access options, it continues to maintain a robust presence through its high-quality publications and rigorous peer-review process aimed at fostering innovation and sharing critical insights across the medical field. Researchers and students alike will find this journal an invaluable platform for disseminating their findings and engaging with current medical discourse.

Integrative Medicine Research

Empowering Research in Integrative Health
Publisher: ELSEVIERISSN: 2213-4220Frequency: 4 issues/year

Integrative Medicine Research, published by Elsevier, is a premier journal dedicated to advancing the field of Complementary and Alternative Medicine. With an impact factor that reflects its esteemed position—ranking 15th out of 105 journals in its category as of 2023 and placing in the 86th percentile—this journal serves as a pivotal platform for researchers, professionals, and students alike. Since its transition to an Open Access model in 2012, it has enhanced the dissemination of critical research, fostering collaboration and application of integrative approaches to health and wellness. The journal encompasses a wide array of topics within its scope, encouraging submissions that contribute to the evidence base of integrative practices and their effects on health outcomes. As a quarterly publication based in South Korea, it emphasizes the importance of global perspectives in research, thereby inspiring innovation in complementary healthcare practices.

Translational Behavioral Medicine

Bridging Research and Clinical Practice in Behavioral Medicine
Publisher: OXFORD UNIV PRESSISSN: 1869-6716Frequency: 4 issues/year

Translational Behavioral Medicine, published by Oxford University Press, is a premier academic journal dedicated to advancing the field of behavioral medicine through high-quality research and innovative methodologies. With an ISSN of 1869-6716 and an impressive E-ISSN of 1613-9860, the journal serves as a vital platform for disseminating findings that bridge the gap between laboratory research and clinical practice. Ranking in the prestigious Q1 category for both Applied Psychology and Behavioral Neuroscience, it holds a prominent position within the academic community, as reflected by its Scopus rankings—17th out of 88 in Behavioral Neuroscience and 57th out of 249 in Applied Psychology. Although currently non-Open Access, the journal provides a wealth of knowledge for researchers, professionals, and students interested in the interplay of behavioral science and health. With converged years from 2011 to 2024, Translational Behavioral Medicine continues to be an essential resource for those committed to enhancing our understanding of how behavioral factors contribute to health and illness.

Reviews on Recent Clinical Trials

Illuminating Recent Breakthroughs in Pharmacology.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1574-8871Frequency: 4 issues/year

Reviews on Recent Clinical Trials, published by Bentham Science Publishers Ltd, is a distinguished journal in the medical and pharmacological fields, assessing the latest advancements in clinical research since its inception in 2006. With a focus on integrating multidisciplinary approaches to evaluating clinical trial methodologies, the journal caters to a diverse audience of researchers, professionals, and students keen on enhancing their knowledge and understanding of innovative therapeutic strategies and drug developments. Notably positioned in the Q3 quartile as ranked by Scopus for both 'Medicine (miscellaneous)' and 'Pharmacology', the journal illustrates a growing academic influence, evidenced by its Scopus rankings—holding a commendable 72nd percentile in general medicine and a 33rd percentile in pharmacology. While the journal is not open access, it remains committed to disseminating high-quality, peer-reviewed content that drives forward the conversation in clinical research. For those interested in staying abreast of novel findings and comprehensive reviews within the clinical trial landscape, Reviews on Recent Clinical Trials stands out as an essential resource.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Pioneering discoveries that shape the future of medicine.
Publisher: ELSEVIER SCIENCE INCISSN: 0002-9629Frequency: 12 issues/year

The American Journal of the Medical Sciences, published by Elsevier Science Inc, has been a cornerstone in the field of medicine since its inception in 1945. With ISSN 0002-9629 and E-ISSN 1538-2990, this esteemed journal provides a comprehensive forum for the dissemination of cutting-edge research and clinical advancements across various medical disciplines. It currently holds a distinguished Q2 ranking in the field of Medicine (miscellaneous) and ranks #118 out of 636 in General Medicine on Scopus, reflecting its significant impact with an 81st percentile rating. While it operates under a traditional publishing model, which ensures rigorous peer-review processes, its commitment to disseminating vital medical knowledge remains paramount. Based in the United States at STE 800, 230 Park Ave, New York, NY 10169, the journal aims to bridge the gap between research and practice, making it an invaluable resource for researchers, healthcare professionals, and students dedicated to advancing medical science and improving patient care.

Complementary Therapies in Clinical Practice

Enhancing clinical practice through scholarly discourse.
Publisher: ELSEVIER SCI LTDISSN: 1744-3881Frequency: 4 issues/year

Complementary Therapies in Clinical Practice is a premier academic journal published by Elsevier Science Ltd, dedicated to advancing the field of complementary and alternative medicine. With an impressive impact factor placing it in the Q1 category for its field and a Scopus rank of 16 out of 105, it serves as a vital platform for sharing high-quality research and clinical insights. Established in 2005 and continuing through 2024, the journal is committed to disseminating evidence-based practices that enhance patient care and safety. Although it does not offer open access, the journal remains integral to researchers, clinicians, and students striving to integrate complementary therapies within conventional healthcare frameworks. Based in the United Kingdom, the journal not only promotes scholarly discourse but also fosters collaboration across an international community of practitioners dedicated to innovative therapeutic approaches.

Russian Open Medical Journal

Empowering healthcare through open access and collaboration.
Publisher: SCIENCE & INNOVATION, LTDISSN: 2304-3415Frequency: 4 issues/year

Russian Open Medical Journal is an esteemed academic publication launched in 2012 by SCIENCE & INNOVATION, LTD, dedicated to advancing the field of medicine and promoting innovative research. As an Open Access journal, it ensures that knowledge is freely accessible to all, fostering collaboration and dissemination of vital medical findings. Based in the Russian Federation, this journal covers a wide array of topics under the domain of general medicine and contributes to the global medical discourse with its commitment to quality research dissemination. With a current Scopus rank of #368 out of 636 in the category of General Medicine, placing it in the 42nd percentile, the journal demonstrates a growing impact within the scientific community. Researchers, healthcare professionals, and students seeking to explore contemporary medical issues will find this journal a valuable resource, reflecting a global perspective while emphasizing innovative solutions to health challenges.

Iranian Journal of Psychiatry and Clinical Psychology

Empowering Minds Through Evidence-Based Insights
Publisher: IRAN UNIV MEDICAL SCIENCESISSN: 1735-4315Frequency: 4 issues/year

The Iranian Journal of Psychiatry and Clinical Psychology, a distinguished publication by IRAN UNIV MEDICAL SCIENCES, serves as a vital platform for the dissemination of research and advancements in the fields of clinical psychology and psychiatry. With its ISSN 1735-4315 and E-ISSN 2228-7515, the journal reaches a diverse audience of researchers, practitioners, and students, specifically in Iran and the broader international community. This open access journal, based in Tehran, facilitates knowledge sharing through its commitment to exploring contemporary issues and emerging trends from 2018 to 2024. Recognized for its significant contributions, it has achieved a Q3 ranking in both Clinical Psychology and Psychiatry and Mental Health categories in 2023, alongside Scopus rankings that place it within the lower quartiles of its respective fields. The journal's aim is to foster a deeper understanding of mental health challenges, promote evidence-based practices, and enhance the quality of mental health care, making it an essential resource for advancing academic and clinical excellence.

Khyber Medical University Journal-KMUJ

Catalyzing progress in pharmacology, toxicology, and public health.
Publisher: KHYBER MEDICAL UNIVISSN: 2305-2643Frequency: 4 issues/year

Khyber Medical University Journal-KMUJ, published by KHYBER MEDICAL UNIVERSITY, serves as a vital platform for the dissemination of research in the fields of Medicine, Dentistry, and Health Professions, among others. Established as an Open Access journal since 2009, KMUJ enables greater accessibility to cutting-edge research, fostering collaboration and knowledge exchange within the medical community. With its headquarters in Kohat, Khyber Pakhtunkhwa, Pakistan, the journal caters to a diverse audience by offering insights into various aspects of healthcare, emphasizing innovation and evidence-based practices. Despite its current Q4 ranking in multiple categories, KMUJ is dedicated to enhancing its impact through rigorous peer-reviewed content, aiming to elevate research standards within the region. As it converges from 2019 to 2024, KMUJ strives to contribute significantly to emerging topics in pharmacology, toxicology, and public health, making it an essential resource for researchers, professionals, and students committed to advancing medical science.